Janne Koskimäki

Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites (2020)

Journal of Magnetic Resonance Imaging

Hobson N, Polster SP, Cao Y, Flemming K, Shu YH, Huston J, Gerrard CY, Selwyn R, Mabray M, Zafar A, Girard R, Carrion-Penagos J, Chen YF, Parrish T, Zhou XJ, Koenig JI, Shenkar R, Stadnik A, Koskimaki J, Dimov A, Turley D, Carroll T, Awad IA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease (2020)

Translational stroke research

McKerracher L, Shenkar R, Abbinanti M, Cao Y, Peiper A, Liao JK, Lightle R, Moore T, Hobson N, Gallione C, Ruschel J, Koskimaki J, Girard R, Rosen K, Marchuk DA, Awad IA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Autoantigen(s) Trigger a Robust Immune Response in Cerebral Cavernous Malformations (2020)

Stroke

Zhang DD, Srinath A, Kinloch AJ, Shenkar R, Shen L, Koskimaki J, Girard R, Lightle R, Moore T, Cao Y, Penagos JC, Romanos S, Lyne S, Shi CB, Awad IA

(Muu (O2))

Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma (2020)

Nature Communications

Polster SP, Sharma A, Tanes C, Tang AT, Mericko P, Cao Y, Carrion-Penagos J, Girard R, Koskimaki J, Zhang DD, Stadnik A, Romanos SG, Lyne SB, Shenkar R, Yan K, Lee C, Akers A, Morrison L, Robinson M, Zafar A, Bittinger K, Kim H, Gilbert JA, Kahn ML, Shen L, Awad IA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Comparative Impact of Timing From Ictus to Intracerebral Hemorrhage Evacuation on Outcome in MISTIE III, STICH I & II Trials (2020)

Stroke

Polster SP, Carrion-Penagos J, Gregson BA, Cao Y, Thompson RE, Stadnik A, Money PL, Koskimaki J, Lyne S, Fam MD, Girard R, Lane K, McBee N, Ziai W, Hao Y, Dodd R, Carlson AP, Camarata PJ, Caron JL, Harrigan MR, Dawson J, Mendelow AD

(Muu (O2))

Common Transcriptomic and Biomarker Signatures in the Aging Brain and in Mendelian Neurovascular Disease, Cerebral Cavernous Malformation (2020)

Stroke

Girard R, Koskimaki J, Polster SP, Li Y, Zhang DD, Romanos S, Carrion-Penagos J, Stadnik A, Lightle R, Moore T, Lyne SB, Hobson N, Cao Y, Srinath A, Shenkar R, Dimov A, Carroll T, Christoforidis GA, Awad IA

(Muu (O2))

Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu (2020)

Journal of Autoimmunity

Zhang DD, Kinloch AJ, Srinath A, Shenkar R, Girard R, Lightle R, Moore T, Koskimaki J, Mohsin A, Carrion-Penagos J, Romanos S, Shen L, Clark MR, Shi CB, Awad IA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A comprehensive p75 neurotrophin receptor gene network and pathway analyses identifying new target genes (2020)

Scientific Reports

Sajanti A, Lyne SB, Girard R, Frantzen J, Rantamaki T, Heino I, Cao Y, Diniz C, Umemori J, Li Y, Takala R, Posti JP, Roine S, Koskimaki F, Rahi M, Rinne J, Castren E, Koskimaki J

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Subclinical Imaging Changes in Cerebral Cavernous Angiomas During Prospective Surveillance (2020)

Stroke

Carrion-Penagos J, Polster SP, Zeineddine HA, Fam MD, Girard R, Koskimaki J, Lyne S, Romanos S, Zhang DD, Srinath A, Cao Y, Stadnik A, Piedad K, Awad IA

(Muu (O2))

Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation (2020)

GeroScience

Koskimaki J, Polster SP, Li Y, Romanos S, Srinath A, Zhang DD, Carrion-Penagos J, Lightle R, Moore T, Lyne SB, Stadnik A, Piedad K, Cao Y, Shenkar R, Dimov AV, Hobson N, Christoforidis GA, Carroll T, Girard R, Awad IA

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Publications

Sort by:

Phantom validation of quantitative susceptibility and dynamic contrast-enhanced permeability MR sequences across instruments and sites (2020)

A Brain-Targeted Orally Available ROCK2 Inhibitor Benefits Mild and Aggressive Cavernous Angioma Disease (2020)

Autoantigen(s) Trigger a Robust Immune Response in Cerebral Cavernous Malformations (2020)

Permissive microbiome characterizes human subjects with a neurovascular disease cavernous angioma (2020)

Comparative Impact of Timing From Ictus to Intracerebral Hemorrhage Evacuation on Outcome in MISTIE III, STICH I & II Trials (2020)

Common Transcriptomic and Biomarker Signatures in the Aging Brain and in Mendelian Neurovascular Disease, Cerebral Cavernous Malformation (2020)

Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu (2020)

A comprehensive p75 neurotrophin receptor gene network and pathway analyses identifying new target genes (2020)

Subclinical Imaging Changes in Cerebral Cavernous Angiomas During Prospective Surveillance (2020)

Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation (2020)